1) In 2002, the mean age of an inmate on death row was 40.7 years. A sociologist wants to test the claim that the mean age of a death-row inmate has changed since then. She randomly selects 32 death-row inmates and finds that their mean age is 38.9 with a sample standard deviation of 9.6 years. Test the claim at the α = 0.05 level of significance. Claim: µ ≠ 40.7 H0: µ = 40.7 H1: µ ≠ 40.7 Critical Value(s) = ± 2.040 Test Statistic = 38.9− 40.7 Fail to reject! Conclusion:There is not sufficient sample evidence to support the claim that the mean age is different from 40.7.
2) Nexium is a drug that can be used to reduce the acid produced by the body and heal damage to the esophagus due to acid reflux. Suppose the manufacturer claims that more than 94% of patients taking Nexium are healed within 8 weeks. In clinical trials 213 of 224 patients were healed after 8 weeks. Test the manufacturers claim at the α = 0.01 level of significance. Claim: P > 0.94 H0: P ≤ 0.94 H1: P > 0.94 Critical value(s) = 2.33 Test Statistic = Fail to Reject! Conclusion:There is not sufficient sample evidence to support the claim that more than 94% of patients are healed within 8 weeks.
3) A researcher claims that the mean height of women today is greater the mean height of women in 1974 which was 63.7 inches. She obtains a simple random sample of 45 women and finds the sample mean to be 63.9 inches. Assume that the population standard deviation is 3.5 inches. Test the researcher’s claim using a level of significance of α = 0.05. Claim: µ > 63.7 H0: µ ≤ 63.7 H1: µ > 63.7 Critical value(s) = 1.645 Test Statistic = Fail to reject! Conclusion: There is not sufficient sample evidence to support the claim that the mean height today is greater than in 1994.
4) A drug company manufactures a 200-mg pain reliever. Specifications demand that the standard deviation of the amount of the active ingredient must not exceed 5 mg. You select a random sample of 30 tablets from a certain batch and find that the sample standard deviation is 7.3 mg. Assume the amount of the active ingredient is normally distributed. Test the claim that the standard deviation of the amount of the active ingredient is greater than 5 mg using α = 0.05. Claim: σ > 5 H0: σ ≤ 5 H1: σ > 5 Critical value(s) = 42.557 Test Statistic = Reject Ho ! Conclusion: The sample data support the claim that σ > 5. Using this data set determine: i) the equation of the linear regression line (y = a + bx) a = 6.55
y = 6.55 – 0.714x ii) the correlation coefficient, r. r = - 0.948 iii) Using α = 0.05, is there a linear correlation between x and y? Critical values = ± 0.811 Claim: ρ ≠ 0, so H0 : ρ = 0 & H1: ρ ≠ 0. Test statistic is r = -0.948 which falls in the critical region so we reject H0. Yes, there is correlation between x & y.
FOR IMMEDIATE RELEASE Contact: Debbie Eisenberg, CTC 814-269-6836 Exelon Corporation’s DC-IN-A-BOX™ Substation, a GridApp™-Supported Core Project, Receives Utility Automation & Engineering T&D 2005 Project of the Year Award Pittsburgh, PA, March 17, 2006— Concurrent Technologies Corporation ( CTC ), operator of the GridApp™ Consortium, today an
Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis ILDIKO R. DUNAY1,2, MARKUS M. HEIMESAAT1, FARIS NADIEM BUSHRAB3, RAINERH. MÜLLER3, HARTMUT STOCKER4, KEIKAWUS ARASTEH4, MICHAEL KUROWSKI5,RUDOLF FITZNER6, KLAUS BORNER6, and OLIVER LIESENFELD1,*Institute for Infection Medicine, Department of Medical Microbiol